AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ordeglim-Duo 1/500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Osiante Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ordeglim-Duo 1/500 Tablet SR

Glimepiride/Metformin extended-release tablets are antidiabetic medications combining two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Administer these tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use, even with controlled blood sugar, is crucial. Discontinuation without medical advice risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, presenting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Ordeglim-Duo 1/500 Tablet SR

No text provided to rephrase.

Uses of Ordeglim-Duo 1/500 Tablet SR

Managing type 2 diabetes

Major Benefits of Ordeglim-Duo 1/500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ordeglim-Duo 1/500 Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this medicine with a meal.

Common Side effects of Ordeglim-Duo 1/500 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ordeglim-Duo 1/500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ordeglim-Duo 1/500 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Ordeglim-Duo 1/500 Tablet SR works:

Ordeglim-Duo 1/500 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ordeglim-Duo 1/500 SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Ordeglim-Duo 1/500 tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Ordeglim-Duo 1/500 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ordeglim-Duo 1/500 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Ordeglim-Duo 1/500 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate Ordeglim-Duo 1/500 Tablet SR treatment at a low dose; it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Ordeglim-Duo 1/500 Tablet SR :

Should you forget a dose of Ordeglim-Duo 1/500 SR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ordeglim-Duo 1/500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ordeglim-Duo 1/500 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ordeglim-Duo 1/500 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Ordeglim-Duo 1/500 Tablet SR and seek immediate medical attention.
Ordeglim-Duo 1/500 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Ordeglim-Duo is not suitable for type 1 diabetes.
Ordeglim-Duo 1/500 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Ordeglim-Duo 1/500 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Ordeglim-Duo 1/500 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Ordeglim-Duo 1/500 Tablet SR and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Ordeglim-Duo 1/500 Tablet...
35
MRP 43
18% off